DGECX
Price
$19.63
Change
-$0.43 (-2.14%)
Updated
Dec 18 closing price
FNWFX
Price
$80.67
Change
-$1.85 (-2.24%)
Updated
Dec 18 closing price
Ad is loading...

DGECX vs FNWFX

Header iconDGECX vs FNWFX Comparison
Open Charts DGECX vs FNWFXBanner chart's image
BNY Mellon Global Emerging Mkts - C
Price$19.63
Change-$0.43 (-2.14%)
VolumeN/A
CapitalizationN/A
American Funds New World F3
Price$80.67
Change-$1.85 (-2.24%)
VolumeN/A
CapitalizationN/A
DGECX vs FNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGECX vs. FNWFX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGECX is a StrongBuy and FNWFX is a Buy.

FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 64B vs. DGECX (407M). FNWFX pays higher dividends than DGECX: FNWFX (1.56) vs DGECX (0.00). DGECX was incepted earlier than FNWFX: DGECX (11 years) vs FNWFX (8 years). DGECX is a more actively managed with annual turnover of: 44.72 vs. FNWFX (32.00). DGECX has a lower initial minimum investment than FNWFX: DGECX (1000) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 12.00 vs. DGECX (7.97). DGECX return over 5 years is better than : 21.93 vs. FNWFX (16.03).
DGECXFNWFXDGECX / FNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years8 years-
Gain YTD6.02510.02760%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets407M64B1%
Annual Yield % from dividends0.001.56-
Returns for 1 year7.9712.0066%
Returns for 3 years-18.020.71-2,539%
Returns for 5 years21.9316.03137%
Returns for 10 years45.83N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRC75.93-0.76
-0.99%
Brady Corp
GEN29.38-0.35
-1.18%
Gen Digital
SACH1.24-0.03
-2.36%
Sachem Capital Corp
NN17.55-0.45
-2.50%
NextNav
CANF1.42-0.09
-5.96%
Can-Fite BioPharma Ltd